Skip to content
Screener

Strata Critical Medical SRTA Q1 2025 earnings

Reported May 12, 2025 · Before market open

Revenue$54.3MMiss by $11.5M
EPS-$0.04Beat by $0.07
Revenue estimate$65.8M
EPS estimate-$0.11

Next report

Nov 9, 2026 (In 3 weeks)
Revenue estimate$72.7M
EPS estimate$0.01

Financials

Q1 2025

Income statement

See full
Revenue$35.9M-30.2%
Gross profit$7.1M-30.4%
Operating income-$5.7M+42.4%
Net income-$3.5M+17.5%
EPS (diluted)-$0.04+33.3%

Balance sheet

See full
Cash & equivalents$35.7M-6.2%
Total debt$9.1M-64.5%
Total equity$219.7M-7.1%
Total assets$250.6M-11.4%

Cash flow

See full
Operating cash flow-$246.0K+98.4%
CapEx$2.6M+220%
Free cash flow-$2.9M+82.5%

Valuation & ratios

Profitability

See full
Gross margin20.4%+0.9pp
Operating margin-17.5%-4.8pp
Net margin-15.1%-3.5pp
FCF margin-11.3%-2.2pp

Returns & leverage

See full
Return on equity-11.6%-3.4pp
Debt / equity0×-0.1×
Current ratio7×-1.4×

FAQ

When did Strata Critical Medical report Q1 2025 earnings?
Strata Critical Medical (SRTA) reported Q1 2025 earnings on May 12, 2025 before market open.
What were Strata Critical Medical's Q1 2025 revenue and EPS?
Strata Critical Medical reported revenue of $54.3M and eps of $-0.04 for Q1 2025.
Did Strata Critical Medical beat estimates in Q1 2025?
Revenue missed the consensus estimate of $65.8M by $11.5M. EPS beat the consensus estimate of $-0.11 by $0.07.
How did Strata Critical Medical's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.4% from $51.5M a year earlier and eps grew 33.3% from $-0.06.
Where can I find Strata Critical Medical's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001779128-25-000039) and the 10-Q periodic report (0001779128-25-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.